Ultrasound of the small joints of the hands and feet: current status
- First Online:
- Cite this article as:
- McNally, E.G. Skeletal Radiol (2008) 37: 99. doi:10.1007/s00256-007-0356-9
- 1.8k Views
The aim of this article was to review the current status of ultrasound imaging of patients with rheumatological disorders of the hands and feet. Ultrasound machines with high-resolution surface probes are readily available in most radiology departments and can be used to address important clinical questions posed by the rheumatologist and sports and rehabilitation physician. There is increasing evidence that ultrasound detects synovitis that is silent to clinical examination. Detection and classification of synovitis and the early detection of bone erosions are important in clinical decision making. Ultrasound has many advantages over other imaging techniques with which it is compared, particularly magnetic resonance. The ability to carry out a rapid assessment of many widely spaced joints, coupled with clinical correlation, the ability to move and stress musculoskeletal structures and the use of ultrasound to guide therapy accurately are principal amongst these. The use of colour flow Doppler studies provides a measure of neovascularisation within the synovial lining of joints and tendons, and within tendons themselves, that is not available with other imaging techniques. Disadvantages compared to MRI include small field of view, poor image presentation, and difficulty in demonstrating cartilage and deep joints in their entirety. Contrast-enhanced magnetic resonance provides a better measure of capillary permeability and extracellular fluid than does ultrasound. The ability to image simultaneously multiple small joints in the hands and feet and their enhancement characteristics cannot be matched with ultrasound, though future developments in 3-D ultrasound may narrow this gap. Magnetic resonance provides a more uniform and reproducible image for long-term follow-up studies.
The small joints of the hands and feet play a central role in the diagnosis and classification of arthropathy. Ultrasound can be used to assess involvement in areas that are clinically occult as well as determine the precise structures involved. Whilst a systematic approach should include a full examination of extra-articular structures, including skin, subcutaneous tissue, the tendon and tendon sheath, the enthesis and associated bursae, this article focuses on intra-articular components of disease, specifically the early detection and classification of effusion, synovitis and erosions. In the patient with arthritis, serial examination can assess current activity and disease distribution, as well as monitoring progression or therapeutic response.
High-frequency linear-array probes are mandatory, probes with operating frequencies of 10 MHz or more providing the best images. The probe should be held lightly between thumb and forefinger (Fig. 1), and the little finger allowed to rest on the table or patient to reduce contact pressure. Excessive probe pressure can obliterate small quantities of fluid, reduce the sensitivity for detection of blood flow and may obscure synovitis. Sagittal images are the mainstay for diagnosis, with axial [metacarpo-phalangeal joint (MCPJ)] and coronal [proximal interphalangeal joint (PIPJ)] images used in support. The superficial structures, including skin, subcutaneous tissue tendon and tendon sheath, should be assessed prior to the joints themselves. Within the joint, the capsule, extra-synovial connective tissue structures, synovium and visible cartilage are examined in turn. The joint should then be moved gently, as it is only during movement that some of the interfaces between the normal structures become sharply defined. Movement may also facilitate detection of low-volume synovial thickening, which bunches up in the proximal extensor recess on flexion.
A comprehensive examination of the small joints of the hands and feet can be time-consuming; however, efficiency can be improved without compromising diagnostic impact, by omitting joints that are commonly negative or misleading. The first ray of both hands and feet often contain effusions, synovial thickening and osteophyte formation in the asymptomatic population. Clinically occult synovial thickening is found more commonly in the PIPJs than in the distal interphalangeal joints (DIPJs) of patients with rheumatoid arthritis (RA) . Unless specifically symptomatic, the DIP joints are not routinely examined in patients with RA, but are included in patients with osteoarthritis or seronegative arthritis or where the diagnosis is unknown, in which cases the tendon insertions should also be included to look for enthesopathy.
Other authors debate whether both the flexor and extensor sides need to be examined. Scheel and co-authors found that, in most cases, synovitis was detected in the palmar and proximal sites of the MCP and PIP joints, with only 14% of affected joints not showing synovitis in these locations  Because of this preponderance, they propose that the examination be streamlined to include only the palmar side. Not all authors agree, and other published work suggests that a significant proportion of synovitis would be overlooked if the examination were to be limited to either one or the other. Ostergaard and Szkudlarek found that only a third of patients had synovitis on both palmar and dorsal aspect of the PIPJ. In the majority, synovitis was limited to one or other compartment, with 43% limited to the palmar  and 27% to the extensor sides. The prevalence is reversed in the metacarpo-phalangeal joints; 80% of synovial thickening will be detected on the extensor aspect. The distribution of synovitis within MCPJs has also received attention [1–3]. Tan et al. used contrast-enhanced MRI and divided the volume of synovitis surrounding each MCP joint into eight sections. They detected a predilection for radial-sided synovitis in the second and third MCPJs, with equal distribution in both sides in the fourth and fifth MCPJs. The distribution on the dorsal versus palmar sides was not published. Hau and colleagues also found a predilection for radial-sided synovitis in the PIPJs . Scheel et al. tested various combinations of joints to determine the most efficient method of providing an overall synovitis score. Synovitis and effusion were not differentiated. Of the various joint combinations tried, counting the medial four MCPJs only was least sensitive, counting the flexor side of the MCP and PIPJs of fingers 2-4 was most sensitive. Whilst this may work well for an overall synovitis score, omitting the fifth ray may reduce the sensitivity for detecting erosions, as the fifth MCPJ and fifth MTPJ are often involved early.
Deep to this is the flexor tendon in its tendon sheath reinforced by the cruciform pulley. The superficial and deep flexor tendons should be independently identified as they pass over the metacarpo-phalangeal joints into the flexor tendon sheath of the fingers. Differences in tendon excursion on finger movement allows the two tendons to be separated easily. The tendon should pass in close proximity to the proximal phalanges where they are held in position by the annular (A2) pulley. The pulleys can be seen as thin poorly reflective linear structures (Fig. 3). Small fluid collections are often seen in relation to them, which are not usually clinically significant.
The proximal recess is the area between the volar aspect of the metacarpal neck and the joint capsule, which abuts the deep surface of the overlying tendon. It is filled with intra-capsular but extra-synovial fat, which normally keeps the two layers of synovium closely approximated to one another. This layer of fat is very much more prominent in the proximal recess on the extensor aspect of the joint, which can extend up to 2 cm. from the joint level. This is to allow for finger flexion . The distal recess is much smaller, as the extensor tendon conforms to the shape of the proximal phalanx.
Absolute measurements of normal joints have not been universally agreed, largely because different workers have used different joints, different parts of joints and different anatomical structures within the joint to define normal dimensions. The variation in the normal was demonstrated by Scheel and co-authors, who looked at the consensus between ultrasonologists involved in training programmes for the European League against Rheumatism (EULAR) . Many of the differences in interpretation were the consequence of failure to appreciate normal findings. Schmidt et al. proposed a standard measurement, using the distance between the sub-chondral cortex on the head of the metacarpal and the volar plate in the second MCPJ. A mean of 1 mm was determined in a group of 102 asymptomatic volunteers , but variation was found to be quite wide. The extensor compartment was not examined, though this area is commonly screened for synovitis . Furthermore, this measurement does not include the proximal recess, where early and prominent synovial thickening may occur. There are also differences between the proximal and distal recesses and some differences between radial and ulna sides, which cannot be encompassed by this single midline measurement.
For these reasons, others use the point of maximal joint distension and compare it with the normal measurement for that location. This, however, varies with the area of the joint being examined, but most authors agree that an increase in joint dimension of more than 1 mm above normal is sufficient to suggest abnormality. On the extensor aspect of the MCPJs, the proximal recess can be measured from bone to the deep surface of the extensor tendon, a distance of approximately 2.5 mm. The distal recess is much smaller, measuring less than 1.5 mm. In the transverse plane, the synovial space is limited on its lateral and medial sides, proximally by the extensor hood and distally by the extensor slips. There should be no posterior bulging of the hood or slips; this finding would suggest focal synovial disease. On the flexor side, the proximal recess is more distended and easier to visualise than the distal recess. The proximal recess measures approximately 3 mm from bone to the deep surface of the tendon. This space includes fat, capsule and two synovial layers, so the space may be increased by hypertrophy of any of these. On high-resolution equipment, the joint cavity itself can be identified between surrounding fat and connective tissue. Occasionally, a small quantity of fluid can be identified, separating the two synovial layers. With increasing practice, ultrasonologists quickly gain an appreciation of the range of normal for the small joints of the hands and feet.
The bony contours of the metacarpal head and proximal phalanx should be smooth, though it is not uncommon to identify a normal indentation on the dorsal aspect of the metacarpal head. This depression is smooth, well demarcated and has reflective bone at its base. It occurs at the site of the fused growth plate and is not associated with overlying synovial thickening. These features allow differentiation from a metacarpal head erosion.
Loose adipose tissue, which surrounds the synovial membrane, lies between flexor tendon and bone. Care must be taken not to misdiagnose this fat as synovial thickening, particularly when its reflectivity is artefactually reduced. On high-resolution equipment, the proximal recess on the flexor side can be differentiated from surrounding fat and connective tissue. The sagittal images are augmented by coronal views, which provide the best depiction of the medial and lateral joint recesses and collateral ligaments. The coronal images are obtained by asking the patient to hyperextend the MCP of the finger being examined (Fig. 1d). Particular attention should be paid to the radial aspect of the joint, where synovial hypertrophy and erosions predominate.
Measuring the joint space on the radial and ulnar side is difficult. This is due to the variable appearances of the ulnar and radial collateral ligaments due to anisotropy. For this reason it is often best to measure from the bone surface to the outer aspect of the collateral ligament. Under normal circumstances this distance is less than 2.5 mm.
The small joints of the forefoot
The metatarso-phalangeal joints and proximal interphalangeal joints of the toes are best examined from the extensor aspect. The big toe is usually not included in the general rheumatological screen, as effusion and bone irregularity are frequently encountered in the asymptomatic population.
On the dorsal aspect of the metatarso-phalangeal joint, extensor digitorum longus and brevis lie superficial to the joint. The extensor digitorum brevis tendon divides into four slips, one to each toe, which run alongside the extensor digitorum longus tendon before inserting into it. The longus tendon itself inserts into the dorsal aspects of the middle and distal phalanges, via the dorsal digital expansions. The dorsal digital expansions have three slips, one central and two collateral. The central slip inserts into the base of the middle phalanx. The collateral slips pass on either side of the inserting central slip and receive reinforcement from the interosseus muscles, the extensor digitorum brevis and the lumbricals. Deep to the extensor tendons, the metatarso-phalangeal joints are reinforced by collateral ligaments that run from dorsal to plantar, crossing the radial and ulnar aspects of the joint. These are difficult to identify individually.
Effusion and synovitis
There is an increasing trend for early and more aggressive treatment of synovitis with disease-modifying anti-rheumatic drugs (DMARDs), which may demonstrate benefit when prescribed even within weeks to months of the onset of disease . The emphasis in early disease detection has now moved from the detection of erosion to the earlier detection of synovitis, and erosions are now generally regarded as being a stage too late. The earliest detectable abnormality within the small joints of the hands and feet is effusion.
Synovial hypertrophy has been measured in a number of ways. Szuldarek categorised changes in synovial thickness by comparing it to bony structures. Grade 1 is minimal synovial thickening (considered normal), grade 2, synovial thickening bulging over the line linking the tops of the bones forming the joint without extension along the bone diaphyses, grade 3, with extension to one of the metadiaphyses and grade 4, extension to both metadiaphyses.
Several studies have shown good inter- and intra-observer reliability of ultrasound classification. The classification by Szkudlarek et al. has been most tested and shown to have good inter-observer agreement. An inter-observer correlation coefficient ( ICC) of 0.61 was determined in a review of 150 small joints of the hand in 30 patients . Naredo and co-workers coordinated a study of 22 ultrasonologists and 28 patients. For the detection of effusion and synovitis in the small joints of the hands and wrists, a mean kappa value of 0.61 was calculated . In a study of 204 hands in normal subjects, Schmidt et al. found a reliability of 0.96 in repeat examinations of the same test subject . Ultrasonography (US) classifications have also been shown to correlate reasonably well with findings on MRI in patients with synovitis, but there have been no studies of the variation that may be found in individuals with normal joints.
High-frequency US can differentiate solid from fluid elements within an enlarged joint space but is less effective at distinguishing inflamed synovium from inactive pannus, fibrous tissue and joint debris. One method of making this differentiation is to use Doppler colour flow, though there has been some variation in the reported findings in individuals with normal joints. Klauser et al.  found that healthy joints showed no intra-articular vascularisation, either before or after the administration of ultrasound contrast medium, while Terslev and colleagues  found vessels in the synovium of the MCPJs of 11 healthy subjects, in 18% before and 50% after administration of contrast agent. Different ultrasound equipment was used, with small differences in probe and Doppler frequencies. Though there is no method of determining for certain whether these differences account for the variation in findings, it is well recognised that sensitivities of ultrasound equipment from different manufacturers vary considerably, and the identification of the occasional blood vessel should probably not be regarded as abnormal when sensitive equipment is being used.
Response to inflammatory changes within the synovium results in the secretion of a large number of inflammatory mediators. Vascular endothelium growth factor (VEGF) is one of the pro-hormones secreted and results in proliferation of the vascular endothelium to form new vessels, a process termed angioneogenesis. Histological studies confirm that power Doppler changes correlate quite well with pathological changes in the synovium [13, 14], although great care should be taken to avoid interface artefact, which can be present at the bone synovium interface if gain settings are too high. Increased Doppler signal correlates especially with polymorphonuclear leucocyte infiltration and surface fibrin deposition , though, as yet, no direct correlation between serum VEGF measurement and neovascularisation has been identified.
There are two ways of measuring synovial blood flow, power Doppler ultrasonography (PDUS) and colour flow Doppler ultrasonography (CFDUS). Power Doppler is more sensitive but also more prone to artefact. It is sensitive to intravenously administered contrast agents which can be used to augment very slow rates of flow. The software that measures power Doppler is proprietary; therefore, results from one manufacturer may not be comparable with another. There is also a concern that serial studies on the same equipment may be incomparable following software or platform upgrades.
Unlike CFDUS, PDUS does not carry specific directional information and will therefore register any flow within the region of interest. Although more recent advances in PDUS mean that some directional information can be imparted in the colour read out, quantification is still based on measuring the amount of colour pixels within the image, rather than an absolute measure of blood flow within the synovial tissue itself. These semi-quantitative measures can be scored either visually or by software analysis. Visual scales are most practicable in the clinical setting. As outlined above, a simple grading system is mild (few scattered vessels), moderate (<50%) or severe, >50% of the synovial exhibiting increased flow. Various other semi-quantitative scales have been proposed, including that of Klauser et al., who counted the number of visible vessels. Grade 1 is 1–5 visible signals, grade 2 6–10 and grade 3 more than 11 vessels in the field of view . Computerised methods involve capturing the ultrasound colour image, importing it into a proprietary photo-package and using the software to differentiate and count the number of colour pixels against the greyscale background . The software method requires standardisation of magnification and field of view and is, therefore, troublesome to apply retrospectively.
CFDUS is less sensitive to motion artefact and is a more objective measurement than is PDUS. Problems include difficulties in acquiring a good trace when angiogenesis is sparse and maintaining the fix as measurements are made, particularly if the equipment freezes the image during measurement. The use of beam steering can sometimes help with vessel fixation. CFDUS is insensitive to contrast agents, which diminishes its usefulness in patients with subtle or early synovitis. Changes in RI can also be induced by increasing probe pressure and by changes in temperature. Serial studies should be carried out at controlled temperature. In most cases this can be achieved simply by ensuring the patient has not just come from an abnormally hot or cold environment to room temperature, though some argue that the use of a water bath is the only means of ensuring reliable temperature control. Probe pressure can be controlled in the usual manner by ensuring that there is always a layer of contact gel between probe and skin.
Terslev et al. demonstrated that Doppler ultrasound using changes in resistive index may be used as a quantitative measurement of blood flow and to detect changes following intra-articular steroid injection . The same group also showed that estimates of synovial activity by Doppler ultrasound was comparable with post-contrast MRI, though there was no association between MRI, ultrasound and estimates of inflammation and pain visual analogue scale (VAS) scores. Changes in RI following treatment with anti-tumour necrosis factor (anti-TNF) have also been demonstrated . Varsamidis and co-authors measured resistive index in the wrists of patients with rheumatoid arthritis. The RI improved as the patients went into clinical remission . The authors also suggest that ultrasound may be able to predict relapse, as patients who had a flare up within 6 months had significantly lower RI following treatment than did patients who remained in stable remission.
Ultrasound contrast agents
Colour Doppler signal from small vessels within the synovium can be augmented by the intravenous administration of contrast agents. When mixed and injected, these agents release bubbles of gas that are sufficiently small to enter the microcirculation. The earliest compounds were mixtures of galactose and palmitic acid microparticles. When hydrated, galactose releases micro-bubbles of air, which adhere to the irregular surface of the palmitic acid microparticles. The air bubbles are approximately 8 μm in diameter and, consequently, are able to enter small capillaries. They remain as a stable level in the circulation for up to 5 min after injection and increase the Doppler signal by approximately 20 dB . Second generation US contrast agents use gases other than air, for example sulphur hexafluoride, to provide ultrasonic contrast.
Because ultrasound involves assessment of a relatively small field of view, the short duration of optimal activity of micro-bubbles following a bolus injection means that there will be different concentrations in the synovium of a joint viewed at the beginning of an ultrasound examination compared with one examined at the end. This compares poorly with the single-time snapshot that can be achieved with intravenous administration of MRI contrast agent, where uptake in all of the joints and tendons within the larger field of view can be assessed simultaneously. There are other disadvantages of bolus administration of ultrasound contrast agents, which include a blooming artefact that can occur due to the sudden arrival of a large quantity of micro-bubbles into the ultrasound field and uneven destruction of micro-bubbles by the US wave acting on the large bolus itself. Administering the contrast agents by infusion rather than bolus injection can overcome some of these issues and yield more stable enhancement for up to 20 min. Three-dimensional ultrasound, with maximum intensity projection algorithms, may also help in overcoming some of these disadvantages and provide a better single-time snapshot image of synovial enhancement.
Contrast-enhanced power Doppler ultrasound (CEPDUS) has been used in a number of clinical studies to demonstrate improved detection, over unenhanced ultrasound, of vascularised synovial tissue. Klauser et al. have done much of this work and have classified neovascularisation in patients with rheumatoid arthritis before and after the administration of contrast agent . In the unenhanced study, 65% of subjects were classified as having normal synovial tissue, grade 0, and 5% as severe, grade 4. Following administration of contrast medium by the infusion technique, only 21% were deemed to have normal synovial tissue, whilst 22% increased to grade 4, with increases in the intermediate groups. Other studies have also demonstrated synovial enhancement and increased detection of synovitis  . CEPDUS shows improved correlation over unenhanced power Doppler compared with arthroscopy . Despite this, the therapeutic impact and outcome value of contrast agents requires further study.
Erosions in RA are most commonly detected on the radial aspects of the heads of the metacarpals and on the bases of the phalanges. The DIPJs are least involved in RA , but more erosions are detected in sero-negative RA and osteoarthritis. In the hands, the second, third and fifth rays are most commonly affected, and, in the feet, the fifth, third and second show the greatest predilection. There are differences between individual joints in the ease by which ultrasound can detect erosions. In the hands, the second and fifth provide the greatest circumferential views at the level of the MCPJs (Fig. 1c). The fourth is the most difficult to examine, especially on its radial and ulnar aspects. Scheel et al. found that ultrasound was superior to MRI in detecting erosions in the proximal interphalangeal joints but was less efficient at the metacarpo-phalangeal joints . Conversely, in Backhaus and colleagues’ study of patients with negative plain film findings, erosions dominated in the MCP joints.
Ultrasound appears to be particularly useful in detecting erosions in patients in the early stages of disease . Erosions detected by US and MRI progress to radiographic detection in the majority of cases [24, 26] within 1 to 2 years. One of the earliest MRI signs of erosion is sub-chondral bone oedema, and there are, as yet, no studies to show that ultrasound is useful in detecting this. Although the contour of the cortex should be carefully examined for clarity and early defects, ultrasound will not appreciate intraosseous abnormalities that are not associated with an overlying surface defect.
Erosions in gout are larger, also irregular, and lie further away from the joint. Erosions must be distinguished from other causes of peri-articular bone irregularities. Entheseal new bone formation at the site of tendon and ligament insertions occur in seronegative arthritis and can give a similar appearance. They are particularly prevalent at the DIPJs, where erosive changes related to osteoarthritis are also found.
Small joint US following treatment
Changes in synovial thickening and vascularisation following treatment can occur rapidly. A reduction in the number of vessels identified within the synovium has been shown by US within 3 days of intravenous corticosteroid administration . Direct interarticular corticosteroid administration has also been shown to reduce the number of synovial vessels, which persist for several years, suggesting that they are a real response to therapy and not just a temporary alteration in flow characteristics induced by pressure changes within the joint [17, 28, 29]. Ultrasound has been used to track changes in total synovial volume by greyscale ultrasound imaging , power Doppler signal [31–33] and resistive index  in response to systemic anti-TNF therapy. Results show a consistent reduction in all these imaging parameters in the early stages of active treatment, though long-term results are less constant. Terslev and colleagues, in a study of wrist and small joint arthritis in patients with rheumatoid disease treated with Etanercept, noted that much of the initial reduction in synovial volume and vascularity and increasing resistive index was lost at 1 year. Conversely, Fiocco et al., in a study of 27 patients with knee involvement from either rheumatoid or psoriatic arthritis, noted that synovial thickening persisted at 3 months’ follow-up but was reduced after 1 year. A reduction in vascularity of the synovium had a more rapid onset and also remained persistently low at 1 year .
The limited evidence would seem to suggest that changes in synovial vascularity can be seen very quickly, independent of the type of treatment used. Changes in synovial volume are slower to respond, and measurable differences may take some time to appear in larger joints. In most studies, these changes appear to persist, suggesting that ultrasound can be used as a marker of early improvement. Furthermore, ultrasound has detected improvements in joints felt to be clinical ‘non-responders’ , suggesting an important role for ultrasound in clinical decision making during the early stage of therapy. Most of these studies, however, are unblinded. Evidence that there is a link between early improvement in synovitis detected by US and a reduction in radiographic findings in later years is beginning to emerge .
Clinical application of ultrasound in small joint arthritis
Ultrasound versus clinical examination
The role of ultrasound in the detection of sub-clinical synovitis has been examined in a number of studies, most of which demonstrate increased detection rates of intra-articular abnormalities. With MRI as the gold standard, the sensitivity, specificity, and accuracy of US for the detection of synovitis in the MTPJs were 0.87, 0.74, and 0.79, respectively, and for clinical examination, 0.43, 0.89, and 0.71, respectively . Wakefield et al. examined the role of ultrasound in detecting sub-clinical synovitis in 1,470 joints in 80 patients with oligoarthritis. Of the clinically unaffected joints, 13% had synovitis detected by ultrasound; the majority, 79%, were metatarso-phalangeal joints, and 16% were metacarpo-phalangeal joints. This meant that one-third of the patients with clinical monoarthritis were upgraded to oligoarthritis (>1<6 joints) and a further quarter to polyarthritis (>6 joints) . Szkudlarek and colleagues examined the metatarso-phalangeal joints in patients with rheumatoid arthritis and healthy controls. Joint effusion and synovitis were detected by ultrasound in 102 joints compared with positive findings in only eight joints on clinical examination . In both studies non-specific findings, especially effusion, common in the first and second MTPJs, may have skewed those results. The finding of occult synovial disease using ultrasound has not been limited to rheumatoid arthritis but has also been extended to patients with systemic lupus erythematosis and other rheumatological conditions .
Ultrasound versus other imaging techniques
Ultrasound has been compared with plain radiography and has shown significantly superior synovitis detection rates. This is unsurprising, as signs of synovitis on plain radiography, including peri-articular osteoporosis, joint space widening and soft tissue swelling, may be difficult to detect and are frequently overlooked. Backhaus et al. demonstrated a fourfold superiority with ultrasound, compared to the plain radiographic findings of peri-articular osteoporosis and soft tissue swelling . In that study, patients with a variety of rheumatological disorders, who had negative findings on plain radiography, had synovitis demonstrated by ultrasound in all cases, whereas MRI was positive in 84%. In the same group, ultrasound detected erosions in 15 patients compared to 26 detected by MRI. More were found in the proximal interphalangeal joints than by MRI, whereas the reverse was true for metacarpo-phalangeal joints, though other authors have not confirmed this .
The use of low-field MRI, sequence choice and the use of lower resolution dynamic rather than static post-contrast MR images may have contributed to the apparent superiority of ultrasound in detecting synovitis. Furthermore, both joint effusion and synovial thickening were interpreted as ‘synovitis’, which might have also increased detection rates for ultrasound over MRI . Conversely, the analogue ultrasound equipment used would be regarded as relatively low specification by modern standards. Indeed, in a follow-up to that study, published 7 years after the original, ultrasound detected more erosions than MRI did, in 49% of patients (9% at baseline) compared to 32% detected by MRI (27% at baseline) . In the follow-up study the original low-resolution analogue ultrasound equipment was replaced by a more advanced digital system. Although there was also an increase in the number of erosions detected by conventional radiography, from 5 to 33 joints, it is more likely that technological improvements in the ultrasound equipment accounted for the greater detection of erosions and that many had been missed at the baseline study. It is, therefore, imperative that superior resolution equipment is used for rheumatological examination. Other studies have confirmed the superiority of ultrasound over radiography in the detection of erosions , independent of the number of projections used .
Contrast-enhanced ultrasound and MRI have been compared in a small number of studies. Terslev et al. compared Doppler ultrasound with quantification of both the colour fraction and RI with synovial thickness on post-contrast MRI . Dynamic enhanced MRI detected more inflamed MCP joints than ultrasound did, but the reverse was true for the wrist. Szkudlarek and colleagues compared contrast-enhanced ultrasound using the bolus technique with post-contrast MRI in actively inflamed MCPJs . The MRI enhancement rates at 55 s after injection were used, as the authors found this to correlate most closely with histological features of synovial inflammation [41–45]. They concluded that there was good correlation between PDUS and MRI, but noted that the diagnostic impact of contrast enhancement was limited to a relatively small number of patients.
Although these studies have attempted to compare ultrasound and MRI contrast enhancement directly, it should be appreciated that there is an essential difference between enhancing synovium on MRI and measurable angioneogenesis on Doppler ultrasound. Enhanced MRI identifies contrast agent in the intravascular, extracellular and joint spaces, the latter depending on the time allowed for diffusion. CEPDUS recognises only new vessel formation within inflamed synovium. It is well recognized that synovial thickening (presumably detectable on enhanced MRI) can be present on ultrasound examination without associated increased vascularity. While it is, therefore, valid to draw some parallels between the two imaging techniques, direct comparison misses vital information on the physiology of the synovium, and differences between them should not be regarded as false negatives or false positives.
Klarlund and co-workers compared MRI, plain radiographs and scintigraphy in 55 patients, followed-up for 1 year. MRI detected progression of erosions more often than radiography did, but ultrasound was not used in that study . Low- and high-field MRI have also been directly compared with plain radiography . The different field strengths had equivalent erosion detection rates, and both were superior to radiography.
Advantages and disadvantages of ultrasound
Conversely, ultrasound has difficulty with large deep joints, superficial joints when there are significant deformities, and in the assessment of articular cartilage. US is a relatively time-consuming procedure, especially if multiple joints are examined. The images acquired can be re-read and reclassified by other readers at a later date, but there is no ability to identify abnormalities overlooked and not imaged at the time of the original examination. MR images can be obtained remotely, reviewed, re-read and scored at a later date and preserved for serial comparison. Increasing use of ultrasound video-loops and 3-D ultrasound may assist in this regard in the future. MRI demonstrates single-time shot synovial enhancement in the entire field of view, which can include all the important small joints of the hands and wrists as well as adjacent tendons and ligaments. Although the time taken to review MRI images of the hand and wrist for diagnostic purposes is probably shorter than the time taken to complete an ultrasound examination, a full MRI score such as the rheumatoid arthritis MRI scoring system (RAMRIS), which is a more close approximation to ultrasound, takes considerably longer. Despite this, there is a strong argument that, for research studies of different therapeutic regimens in patients with rheumatoid arthritis, plain films and MRI provide more robust serial assessment and will remain the gold standard for some time.
In routine rheumatological practice, ultrasound of the small joints of the hands and feet accurately detects occult synovial disease and allows classification of the extent and activity of synovitis as well as superior detection of erosions in comparison with radiography. US can guide intra-articular therapy as well as assess its response and the response to systemic treatment. Future goals for ultrasound trials need to include further validation studies, studies of diagnostic and therapeutic impact and longer term outcomes from clinical and therapeutic decisions based on the ultrasound examinations.